Mark Volpe

Senior Vice President, Tax · Regeneron Pharmaceuticals

Biopharmaceuticals

Mark Volpe is senior vice president of tax at Regeneron Pharmaceuticals. He joined in 2012 after tax roles at Arthur Andersen, Ernst & Young and Diageo. He also serves as secretary and trustee of Intensive Therapeutics.

Last reviewed: Oct 21, 2026

Mark Volpe

Senior Vice President, Tax Regeneron Pharmaceuticals

Last Reviewed: October 21, 2026

Executive Summary

Mark Volpe is senior vice president of tax at Regeneron Pharmaceuticals. He joined in 2012 after tax roles at Arthur Andersen, Ernst & Young and Diageo. He also serves as secretary and trustee of Intensive Therapeutics.

Career Highlights

  • Joined Regeneron in 2012.
  • Previously worked on tax teams at Arthur Andersen, Ernst & Young and Diageo.
  • Serves as secretary and trustee of Intensive Therapeutics.

Professional Journey

Volpe developed his tax career through positions at Arthur Andersen, Ernst & Young and Diageo before joining Regeneron in 2012. His background combines professional services and an operating company tax organization.

He now serves as senior vice president of Tax at Regeneron. His education spans accounting, undergraduate study and law, providing the documented academic background accompanying his tax leadership.

Outside his corporate role, Volpe serves as secretary and a member of the board of trustees of Intensive Therapeutics. The nonprofit provides therapy services to children with special needs. That governance service is separately identified in the company’s current biography.

Education

Volpe earned an AS in accounting from Suffolk County Community College, a BA from the State University of New York at Albany and a JD from Saint John’s University.